Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

£28.5m in funding has been announced to support functional genomics research across the UK, including a research cluster at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) that will deliver insights into musculoskeletal health and disease.

Pipetting liquid

The Medical Research Council (MRC), in collaboration with the Biotechnology and Biological Sciences Research Council (BBSRC), has provided £28.5 million in funding to establish the Human Functional Genomics Initiative programme. 

It aims to advance our understanding of how genomic variation influences human physiology and how it changes over time and in disease.

The funding supports four research clusters that will focus on technology development and research into genomic variation in a range of disease areas.

Professor Dominic Furniss at NDORMS will lead a cluster Harnessing the interplay of genetics, cells and matrix to deliver insights into musculoskeletal health and new therapies in musculoskeletal disease. Together with his team he will use a variety of functional genomics techniques to:

  • boost our understanding of musculoskeletal health and disease
  • generate therapeutic targets for future studies
  • provide tools and training for the wider community

 

Read the full story in the NDORMS website.